Practical implications of the ASTRO Radiation Oncology Case Rate Program (ROCR) proposal for radiation oncologists.

The American Society for Radiation Oncology (ASTRO) has proposed the Radiation Oncology Case Rate Program (ROCR) to advocate for fair reimbursement for radiation oncologists.  ROCR would replace Medicare fee-for-service with a case rate payment for each of the 15 most common cancer types treated with external beam or stereotactic radiation therapy. This topic discussion attempts to provide a concise overview of the practical implications for radiation oncologists should the ROCR payment program be legislated by Congress and subsequently implemented by the Center for Medicare and Medicaid Services (CMS). This topic discussion covers the practical changes to billing and reimbursement, the Health Equity Achievement in Radiation Therapy (HEART) payment, the Quality of Care requirement, and the available tool to calculate the impact of the ROCR based on an individual practice's case mix.

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Conflict of Interest Statement Dr. Yu reports a research grant from Pfizer/Myovant paid to his institution, and consulting and speaking fees from Pfizer / Myovant, Boston Scientific, and RefleXion Medical. Dr. Luh reports consulting fees from EMD Serono, Aptitude Health, and the Cooperative of American Physicians. As well he is a shareholder with Bridge Oncology LLC, and a shareholder and officer with Actimatech, Inc. Dr. Mantz reports no conflicts of interest.